LCC in Cantonese: Novel Treatment for Advanced EGFR-mutant NSCLC

Podcast | Cantonese | 2025 | 60 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Rina Hui and Dr. Zhang Li. This episode is part of our Virtual Tumor Board series and will focus on managing EGFR-mutant NSCLC.

Podcast Guest Host:

Molly Li, MD, Clinical Assistant Professor, Department of Clinical Oncology, CUHK, Hong Kong, China

Podcast Guests:

Rina Hui, MBBS, PhD, FRACP, Director, Centre of Cancer Medicine, HKU Med, Adjust Professor, University of Sydney, Clinical Professor, University of Hong Kong, China
Zhang Li, MD, Professor, Medical Oncology, Department Deputy Director, Lung Cancer Research Center, Sun Yat-Sen University, Guangzhou, China